These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30048676)

  • 1. Notch signaling in human iPS-derived neuronal progenitor lines from Focal Cortical Dysplasia patients.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    Int J Dev Neurosci; 2018 Oct; 69():112-118. PubMed ID: 30048676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration and Synaptic Aspects of Neurons Derived from Human Induced Pluripotent Stem Cells from Patients with Focal Cortical Dysplasia II.
    Majolo F; Marinowic DR; Palmini ALF; DaCosta JC; Machado DC
    Neuroscience; 2019 Jun; 408():81-90. PubMed ID: 30902678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of genes involved in cell proliferation, adhesion, and control of apoptosis during embryonic neurogenesis in Induced Pluripotent Stem Cells (iPSCs) from patients with Focal Cortical Dysplasia.
    Marinowic DR; Majolo F; Zanirati GG; Plentz I; Neto EP; Palmini ALF; Machado DC; Da Costa JC
    Brain Res Bull; 2020 Feb; 155():112-118. PubMed ID: 31816405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells from patients with focal cortical dysplasia and refractory epilepsy.
    Marinowic DR; Majolo F; Sebben AD; da Silva VD; Lopes TG; Paglioli E; Palmini A; Machado DC; da Costa JC
    Mol Med Rep; 2017 Apr; 15(4):2049-2056. PubMed ID: 28260047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
    Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
    Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR pathway activation in focal cortical dysplasia.
    Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA Methylation and RNAseq Analyses Identify Aberrant Signalling Pathways in Focal Cortical Dysplasia (FCD) Type II.
    Dixit AB; Sharma D; Tripathi M; Srivastava A; Paul D; Prakash D; Sarkar C; Kumar K; Banerjee J; Chandra PS
    Sci Rep; 2018 Dec; 8(1):17976. PubMed ID: 30568293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K-AKT pathway polymerase chain reaction (PCR) array analysis of epilepsy induced by type II focal cortical dysplasia.
    Lin YX; Lin K; Liu XX; Kang DZ; Ye ZX; Wang XF; Zheng SF; Yu LH; Lin ZY
    Genet Mol Res; 2015 Aug; 14(3):9994-10000. PubMed ID: 26345935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTOR pathway in focal cortical dysplasia type 2: What do we know?
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    Epilepsy Behav; 2018 Aug; 85():157-163. PubMed ID: 29945038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.
    Yao K; Duan Z; Zhou J; Li L; Zhai F; Dong Y; Wang X; Ma Z; Bian Y; Qi X; Li L
    Oncotarget; 2016 Nov; 7(47):76415-76422. PubMed ID: 27811355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Altered Micro RNA Expression Profiles in Focal Cortical Dysplasia IIB.
    Li L; Liu CQ; Li TF; Guan YG; Zhou J; Qi XL; Yang YT; Deng JH; Xu ZQ; Luan GM
    J Child Neurol; 2016 Apr; 31(5):613-20. PubMed ID: 26442942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE
    Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients.
    Srivastava A; Kumar K; Banerjee J; Tripathi M; Dubey V; Sharma D; Yadav N; Sharma MC; Lalwani S; Doddamani R; Chandra PS; Dixit AB
    Mol Brain; 2021 Jul; 14(1):120. PubMed ID: 34301297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial omics reveals molecular changes in focal cortical dysplasia type II.
    Vermeulen I; Rodriguez-Alvarez N; François L; Viot D; Poosti F; Aronica E; Dedeurwaerdere S; Barton P; Cillero-Pastor B; Heeren RMA
    Neurobiol Dis; 2024 Jun; 195():106491. PubMed ID: 38575092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Jha R; Kurup A; Kovilapu UB; Ranjan R; Sondhi V
    Brain Dev; 2022 Feb; 44(2):166-172. PubMed ID: 34756499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.